Figure 1 | Modern Pathology

Figure 1

From: Androgen-receptor splice variant-7-positive prostate cancer: a novel molecular subtype with markedly worse androgen-deprivation therapy outcomes in newly diagnosed patients

Figure 1

Representative immunohistochemical (IHC) and hematoxylin–eosin (H&E) staining. (a, d, g, j) H&E staining; (b, e, h, k) immunohistochemical staining for N-terminal androgen-receptor full-length (AR-FL) and (c, f, i, l) immunohistochemical staining for AR-V7 in two representative biopsy cores. The first and second rows are AR-V7-positive from consecutive tissue sections, and the third and fourth rows are AR-V7-negative. Original magnification: × 200 (a, b, c, g, h, i) and × 400 (d, e, f, j, k, l).

Back to article page